AS2541019
CAS No. 2098906-98-8
AS2541019( AS 2541019 )
Catalog No. M13323 CAS No. 2098906-98-8
AS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAS2541019
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM.
-
DescriptionAS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM, >100-fold selectivity over other PI3K isoforms; inhibits Akt phosphorylation in human Ramos B cell line with IC50 of 14.3 nM, effectively inhibits anti-IgM stimulated B cell proliferation and human B cell proliferation with IC50 of 4.3 and 3.6 nM, respectively; significantly inhibits both T-dependent and T-independent de novo antibody production in peripheral blood in vivo; significantly prolongs graft survival time by inhibiting xenoreactive antibody production in rat concordant xenotransplant model.
-
In Vitro——
-
In Vivo——
-
SynonymsAS 2541019
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2098906-98-8
-
Formula Weight529.593
-
Molecular FormulaC26H33F2N7O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@H]1CC[C@H](OC2=NC(N3CCOCC3)=NC(N4C(C(F)F)=NC5=CC=CC=C45)=C2)CC1)CN(C)C
-
Chemical NameN-[trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)cyclohexyl]-2-(dimethylamino)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marui T, et al. Eur J Pharmacol. 2018 Mar 5. pii: S0014-2999(18)30133-X.
molnova catalog
related products
-
GDC-0084
A potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively.
-
PARP,PI3K-IN-1
PARP/PI3K-IN-1 is a novel dual poly (ADP-ribose) polymerase (PARP) and phosphatidylinositol 3-kinase (PI3K) dual inhibitor with anticancer, antitumour and antiproliferative activities for the study of breast, pancreatic and lung cancers.
-
PKI-402
A potent dual PI3K/mTOR inhibitor.
Cart
sales@molnova.com